| Product Code: ETC9969736 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Malaria Vaccine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Malaria Vaccine Market - Industry Life Cycle |
3.4 United States (US) Malaria Vaccine Market - Porter's Five Forces |
3.5 United States (US) Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 United States (US) Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in global travel and migration to malaria-endemic regions |
4.2.2 Rising awareness about the importance of malaria prevention |
4.2.3 Government initiatives and funding for malaria eradication programs |
4.2.4 Technological advancements in vaccine development |
4.2.5 Growing prevalence of drug-resistant malaria strains |
4.3 Market Restraints |
4.3.1 High cost of vaccine development and distribution |
4.3.2 Regulatory challenges and lengthy approval processes |
4.3.3 Limited access to healthcare in remote areas |
4.3.4 Vaccine hesitancy and misinformation |
4.3.5 Competition from existing preventive measures such as bed nets and insecticides |
5 United States (US) Malaria Vaccine Market Trends |
6 United States (US) Malaria Vaccine Market, By Types |
6.1 United States (US) Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 United States (US) Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 United States (US) Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 United States (US) Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 United States (US) Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 United States (US) Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 United States (US) Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 United States (US) Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 United States (US) Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 United States (US) Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 United States (US) Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 United States (US) Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 United States (US) Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 United States (US) Malaria Vaccine Market Import-Export Trade Statistics |
7.1 United States (US) Malaria Vaccine Market Export to Major Countries |
7.2 United States (US) Malaria Vaccine Market Imports from Major Countries |
8 United States (US) Malaria Vaccine Market Key Performance Indicators |
8.1 Number of individuals vaccinated against malaria |
8.2 Rate of malaria cases in vaccinated population |
8.3 Research and development investment in malaria vaccines |
8.4 Adoption rate of new malaria vaccines |
8.5 Number of partnerships and collaborations in the malaria vaccine market |
9 United States (US) Malaria Vaccine Market - Opportunity Assessment |
9.1 United States (US) Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 United States (US) Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Malaria Vaccine Market - Competitive Landscape |
10.1 United States (US) Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here